Beta-carotene effects serum lipoproteins immunologic indices humans Doses beta-carotene cancer-prevention trials epidemiologic data Mechanisms putative antineoplastic effects beta-carotene unknown modulation immune system plasma carotenoid concentrations immunologic indices baseline wk healthy humans groups mg beta-carotene/d mo randomized placebo-controlled open-label parallel study Plasma beta-carotene concentrations wk dose Beta-carotene concentrations wk group dose-concentration curve beta-carotene-dose selection target plasma concentrations unable effects beta-carotene ingestion immunologic indices modest increases high-density-lipoprotein cholesterol beta-carotene-treated groups 